4//SEC Filing
Mazur Leonard L 4
Accession 0001213900-24-069248
CIK 0001851484other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 6:27 PM ET
Size
11.8 KB
Accession
0001213900-24-069248
Insider Transaction Report
Form 4
Mazur Leonard L
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-12+1,233,333→ 1,233,333 totalExercise: $2.15Exp: 2033-07-05→ Common Stock (1,233,333 underlying)
Footnotes (1)
- [F1]This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.
Issuer
CITIUS ONCOLOGY, INC.
CIK 0001851484
Entity typeother
Related Parties
1- filerCIK 0001463414
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 6:27 PM ET
- Size
- 11.8 KB